Last reviewed · How we verify
NCT03667794
Evaluation of Novel Lung Function Parameters in Patients With Pulmonary Hypertension (PH)
trial testing body plethysmography in Pulmonary Hypertension in 75 participants. Completed in 31 July 2017.
31 July 2017
Quick facts
| Lead sponsor | Universitätsmedizin Mannheim |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 75 |
| Start date | 1 July 2015 |
| Primary completion | 31 July 2017 |
| Estimated completion | 31 July 2017 |
Drugs / interventions tested
- body plethysmography
- impulse oscillometry
- multiple breath washout
Conditions studied
- Pulmonary Hypertension — all drugs for Pulmonary Hypertension →
Sponsor
Universitätsmedizin Mannheim — full company profile →
Who can join
Adults 18 to 99, any sex, with Pulmonary Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Little is known about affection of small airways in patients with pulmonary hypertension as well as the ideal diagnostic approach. The investigators therefore aimed to evaluate novel or not widely used lung function tests for the evaluation of airway function in patients with PH.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Small Airway Disease in Pulmonary Hypertension-Additional Diagnostic Value of Multiple Breath Washout and Impulse Oscillometry.
Trinkmann F, Gawlitza J, Künstler M, Schäfer J, et al · · 2018 · cited 9× · PMID 30544842 · DOI 10.3390/jcm7120532
Verify or expand the search:
- PubMed search for NCT03667794
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pulmonary Hypertension
Currently open trials in the same condition.
- NCT07179380 — Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension · Phase 3 · recruiting
- NCT07073820 — A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P · Phase 2 · recruiting
- NCT06351345 — 129 Xenon Imaging in Patients Treated With Sotatercept · Phase 2 · recruiting
- NCT07187206 — Safety and Efficacy of FETO in CDH Phase III · Phase 3 · recruiting
- NCT07206173 — Londrina Activities of Daily Living Protocol in Pulmonary Hypertension · recruiting
Other Universitätsmedizin Mannheim trials
Trials by the same sponsor.
- NCT06416319 — Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct) · NA · recruiting
- NCT04534998 — Robotic-assisted vs. Open Partial Nephrectomy · Phase 2 · unknown
- NCT05575856 — Cardiogenic Shock Registry Mannheim · unknown
- NCT04146701 — Metabolomics and Microbiomics in Cardiovascular Diseases · unknown
- NCT04533633 — German Epicardial Collateral CTO Registry · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03667794 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitätsmedizin Mannheim
- Last refreshed: 14 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03667794.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing